Top News

TR Life Sciences Successfully Delivers 40Healthcare Projects in Tier 2 Towns

TR Life Sciences, a leading hospital management consulting firm, has announced it has successfully delivered 40 hospital and other healthcare consultancy projects across the country in the last 5 years, while 15 new projects are underway.

The hospital projects, totaling over 1,500 beds, have been executed in Nepal and states like Bihar, Jharkhand, Madhya Pradesh, Haryana, Delhi-NCR, Punjab, Gujarat, Uttar Pradesh, Uttarakhand, Rajasthan, and Maharashtra.

Said Dr. Gopal Sharan, Managing Director, TR Life Sciences, New Delhi: “Successfully executing 40 projects, most of them in tier 2 and 3 towns across North India, is a huge milestone for us in a span of five years. This showcases the huge unmet need that exists in the hinterland for handholding entrepreneurs with cutting-edge advice and expertise to set up small-size hospitals of up to 350 beds. It is immensely satisfying for us to contribute to the creation of state-of-the-art healthcare infrastructure beyond the big cities and elevate the standards of care available to patients. Our vision is to improve healthcare standards and medical outcomes in tier-II and tier-III cities in India.”

Dr. Gopal Sharan added: “Since our inception in 2018, we have been experiencing robust growth in the small hospital segment, riding on the back of our services like project planning and advisory, operations management, business model and feasibility study, financial planning and budgeting, structuring advisory, clinical technology assessment, architectural design, fundraising, healthcare startup advisory, and mergers & acquisitions.”

Recounting the milestones, he said: “In 2020, we developed inhouse new-age hospital information system and business intelligence tools. Two years later, we expanded our service offerings by adding project designing, project advisory, and automation for clients. This year, we have ventured into projects to set up specialized cardiology centers, both standalone and inside hospitals, in Tier II and III towns to meet the huge demand.”

TR Life Sciences was established in 2018 with a mission to enhance the quality of healthcare by providing state-of-the-art services in project planning, design, development, and management operations. The projects are situated in various regions of India and Nepal, reflecting the company’s commitment to advancing healthcare accessibility and delivery.

TR Life Sciences enables its healthcare clients to uncover hidden insights, explore scientific options, and forge difficult strategic choices. It helps them understand the healthcare market landscape by analyzing industries, profiling competition, sizing markets, segmenting customers, determining the best distribution channels, evaluating the most appropriate site locations for new projects, preparing investment feasibility studies, reviewing potential joint ventures or acquisitions, and deliver market entry and growth strategy in India.

The company’s experts collate, mine, and model data with insights generated through past experiences with healthcare professionals and other key decision-makers to drive strategic recommendations that meet its clients’ needs.

Medlarge

Recent Posts

Air pollution spikes inflammation in patients with heart disease: Study

Patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts…

2 days ago

Health ministry writes to all states on alarming air pollution, fire incidents

As the air pollution levels spike and reached alarming levels in many cities across the…

3 days ago

‘Antimicrobial Resistance a global health threat’

Highlighting that Antimicrobial Resistance is a global health threat, the Minister of State for health…

4 days ago

SFI marathon held at Indirapuram

SFI Green Heartfulness Run was held on November 17, 2024 at Indirapuram starting from Habitat…

4 days ago

ICMR starts first in-human clinical trials for Zika vaccine

The Indian Council of Medical Research (ICMR) has inked agreements with multiple stakeholders for the…

2 months ago

Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease

Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable…

2 months ago